SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: U54CA260491
National Institutes of Health
Grant: U01AI138897
national institutes of health
Grant: K08AI156021
NIGMS NIH HHS
Grant: T32 GM136577
NCI NIH HHS
Grant: U54 CA260492
National Institutes of Health
Grant: 5K08AI156021-04
Modulation of Herpes Simplex Virus Pathogenesis by Leucine Rich Repeat Kinase 2
National Institutes of Health
Grant: 4U54CA260492-02
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
National Institutes of Health
Grant: 3U01AI138897-05S1
HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation
FWCI
1.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals